Jan Nilsson
Direktor/Vorstandsmitglied bei Aptahem AB
Ursprung des Netzwerks ersten Grades von Jan Nilsson
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Aptahem AB
 Aptahem AB Pharmaceuticals: MajorHealth Technology Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden.
11
| Public Company | Pharmaceuticals: Major | 11 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Jan Nilsson
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| GABATHER AB | Pharmaceuticals: Major | Founder Director/Board Member Founder Director of Finance/CFO Director/Board Member | |
| CYXONE AB | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member Chief Executive Officer | |
| University of Lund | College/University | Director/Board Member Doctorate Degree Graduate Degree Undergraduate Degree | |
| University of Uppsala | College/University | Doctorate Degree Corporate Officer/Principal | |
| Ideonfonden AB | Director/Board Member Chief Executive Officer | ||
| Accequa GmbH | Director/Board Member Director/Board Member | ||
| Galecto Biotech AB | Founder Founder | ||
| Accequa AB | Chairman Founder | ||
| Mikeoo Holding AB | Founder | ||
| Serstech Förvaltning AB | Founder | ||
| Portendo Standoff Detection AB | Founder | ||
| Ceratmo AB | Director/Board Member | ||
| BIOINVENT INTERNATIONAL AB | Biotechnology | Chief Executive Officer | |
| Aptahem Finans AB | Founder | ||
| University of Detroit Mercy School of Law | College/University | Graduate Degree | |
| Mylifeproducts AS | Chairman | ||
Advokatfirmaet Nova Da
 Advokatfirmaet Nova Da Miscellaneous Commercial ServicesCommercial Services Advokatfirmaet Nova Da is a medium-sized law firm based in Oslo, Norway with additional offices in Volda and Bodø. The firm has been providing high-quality legal assistance since 1995 and offers a free case evaluation. Nova prides itself on its innovative approach while maintaining a strong foundation of expertise and experience. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Farma Investment AS
 Farma Investment AS Real Estate Investment TrustsFinance Farma Investment AS invests in shares and real properties. The company was founded on June 23, 2011 and is headquartered in Oslo, Norway. | Real Estate Investment Trusts | Chairman | |
| Nova Law Firm | Corporate Officer/Principal | ||
Langseth Advokatfirma DA
 Langseth Advokatfirma DA Miscellaneous Commercial ServicesCommercial Services Langseth Advokatfirma Da is a law firm based in Oslo that offers legal advice and procedure assistance to private individuals and companies. The firm has a team of talented lawyers with extensive experience in dispute resolution, including in court if necessary. One of the main focus areas of the firm is cabin and leisure adjustments, in addition to common legal issues related to real estate. The subject group is led by lawyers with extensive experience in this area. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Melius Pharma AB
 Melius Pharma AB Pharmaceuticals: MajorHealth Technology Melius Pharma AB is a Swedish clinical stage pharmaceutical company that develops new treatments for chronic cough in idiopathic pulmonary fibrosis (IPF) patients. The company is based in Lund, Sweden and is privately owned, benefiting from the support of two of Sweden's most prominent professional life science investors who bring expertise to develop the company. IPF is a chronic, progressive lung inflammation characterized by fibrosis and disruption of normal lung architecture. Melius Pharma has developed ME-015, which stabilizes ion channels in the neuronal endings in the lungs that mediate cough. ME-015 is presumed to have an acute effect and is a solution for chronic cough, which is one of the major symptoms experienced by 80%% of IPF patients. | Pharmaceuticals: Major | Director/Board Member | |
| Holy Plantmedix AB | Founder | ||
| Biovotec A/S | Director/Board Member | ||
IQVIA Clinical AB
 IQVIA Clinical AB Pharmaceuticals: MajorHealth Technology IQVIA Clinical AB delivers information and technology solutions for healthcare purposes. It specializes in primary care, hospital, and specialist products. The company was founded in 1984 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SENSIDOSE AB | Electronic Equipment/Instruments | Director/Board Member | |
| Université de Bordeaux | College/University | Graduate Degree | |
| ARCEDE PHARMA AB | Miscellaneous Commercial Services | Director/Board Member | |
| Swedish Pharmaceutical Society | Director/Board Member | ||
| EMOTRA AB (PUBL) | Medical Specialties | Director/Board Member | |
| Medcom-Advice AB | Director/Board Member | ||
H. Lundbeck AB
 H. Lundbeck AB Pharmaceuticals: MajorHealth Technology H. Lundbeck AB operates as a pharmaceutical company specializing in psychiatric and neurological disorders. It offers a broad range of products within brain diseases such as depression, schizophrenia, Alzheimer, and Parkinson. The company is headquartered in Malmo, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ledningsresurs Syd AB
 Ledningsresurs Syd AB Miscellaneous Commercial ServicesCommercial Services Ledningsresurs Syd AB provides corporate consulting services. Ola Skanung has been the CEO of the Swedish company since 2010. | Miscellaneous Commercial Services | Chief Executive Officer | |
Otsuka Pharma Scandinavia AB
 Otsuka Pharma Scandinavia AB Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharma Scandinavia AB is a pharmaceutical and nutraceutical company based in Stockholm, SE. Otsuka Pharma Scandinavia aims to improve the health of patients by focusing on some of the world's unresolved health issues and creating solutions and opportunities for some of the most challenging conditions of the body and mind. Otsuka Pharma Scandinavia is dedicated to making a difference for patients in their daily lives and focuses on getting the job done together as a team, guided by its values of integrity, compassion, excellence, creativity, and collaboration. The Swedish company is committed to conducting business ethically and in compliance with the laws and regulations of the countries where it operates. The company invests substantially in research and development in both common and rare conditions, with a network of 44 research institutes around the world. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Gothenburg | College/University | Doctorate Degree | |
| BICO GROUP AB | Biotechnology | Director/Board Member | |
| FOLLICUM AB (PUBL) | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Imperial College London | College/University | Doctorate Degree | |
| XO Sweden Wines & Spirits AB | Director/Board Member | ||
| INVENT MEDIC SWEDEN AB | Medical Specialties | Director of Finance/CFO | |
| Ff Bygg Og Vedlikehold AS | Director/Board Member | ||
| AQUA BIO TECHNOLOGY ASA | Chemicals: Major Diversified | Director/Board Member | |
Region Skåne Holding AB
 Region Skåne Holding AB Advertising/Marketing ServicesCommercial Services Region Skåne Holding AB is a private company based in Malmö, Sweden, with subsidiaries in Sweden. The Swedish company provides a free service that helps businesses improve their online presence and increase their visibility on Google search and maps. By creating a unique and eye-catching company profile, potential customers can easily find important information such as opening hours, address, and contact details. In collaboration with the city of Malmö, the company is working on developing sustainable tourism through the promotion of train travel. The goal is to reduce the negative climate impact of tourism by encouraging travelers to choose train travel over flights. The company's strategies are based on cooperation with actors who can make a difference, such as Skånetrafiken, SJ, tour operators, and property owners of train stations. Region Skåne Holding AB aims to empower Skåne's event and hospitality industry. | Advertising/Marketing Services | Director/Board Member | |
| Cardio Vax LLC | Director/Board Member | ||
| Balx 4 AB | Director/Board Member | ||
Forskarpatent i Syd AB
 Forskarpatent i Syd AB Miscellaneous Commercial ServicesCommercial Services Forskarpatent i Syd AB specialises in the commercialisation, through licensing or new venture spinouts, of patentable inventions emanating mainly from Swedish universities. It holds a portfolio of projects in the format of shares in spinouts, partnered (licensed) and still unpartnered assets. It is involves in projects in pharmaceutical, technology, and food categories. The firm is categorized under patent agency operations. The company was founded on January 18, 1996 and is headquartered in Lund, Sweden. | Miscellaneous Commercial Services | Chief Executive Officer | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Chief Executive Officer | |
Laccure AB
 Laccure AB Pharmaceuticals: GenericHealth Technology Laccure AB develops products for the treatment and prevention of bacterial vaginosis. It is a pharmaceutical company that offers non-prescription vaginal tablet for women. The firm's product is based on a proprietary substance that releases lactic acid over an extended period of time to decrease elevated vaginal potential of hydrogen. It engages in research, development, training, marketing, and sales in the field of skin care and hygiene activities. The company was founded by Olov Arvid Sterner in 2007 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Generic | Chairman |
Statistik
International
| Schweden | 35 |
| Norwegen | 10 |
| Vereinigte Staaten | 3 |
| Dänemark | 3 |
| Schweiz | 2 |
Sektoral
| Health Technology | 17 |
| Consumer Services | 7 |
| Commercial Services | 7 |
| Finance | 2 |
| Electronic Technology | 2 |
Operativ
| Director/Board Member | 60 |
| Founder | 17 |
| Chairman | 12 |
| Corporate Officer/Principal | 12 |
| Chief Executive Officer | 9 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Jan Nilsson
- Unternehmensverbindungen
